Piperidine,2-[(2S,4S)-2-ethyl-2-phenyl-1,3-dioxolan-4-yl]-, (2S)- structure
|
Common Name | Piperidine,2-[(2S,4S)-2-ethyl-2-phenyl-1,3-dioxolan-4-yl]-, (2S)- | ||
|---|---|---|---|---|
| CAS Number | 28189-85-7 | Molecular Weight | 261.35900 | |
| Density | 1.057g/cm3 | Boiling Point | 373ºC at 760mmHg | |
| Molecular Formula | C16H23NO2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 157.4ºC | |
Use of Piperidine,2-[(2S,4S)-2-ethyl-2-phenyl-1,3-dioxolan-4-yl]-, (2S)-Etoxadrol is a potent N-methyl-D-aspartic acid (NMDA) antagonist with high affinity. Etoxadrol can be used for anaesthetic research[1]. |
| Name | 2-(2-ethyl-2-phenyl-1,3-dioxolan-4-yl)piperidine |
|---|---|
| Synonym | More Synonyms |
| Description | Etoxadrol is a potent N-methyl-D-aspartic acid (NMDA) antagonist with high affinity. Etoxadrol can be used for anaesthetic research[1]. |
|---|---|
| Related Catalog | |
| Target |
NMDA[1] |
| In Vivo | Etoxadrol (100.0 mg/kg; i.h.; 30 min) produces marked stimulation and ataxia in mice[2]. Animal Model: Carworth-Farm (Upjohn) male mice weighing 18 to 20 gm[2] Dosage: 100.0 mg/kg Administration: Subcutaneous injection, 30 min Result: Produced marked stimulation and ataxia. |
| References |
| Density | 1.057g/cm3 |
|---|---|
| Boiling Point | 373ºC at 760mmHg |
| Molecular Formula | C16H23NO2 |
| Molecular Weight | 261.35900 |
| Flash Point | 157.4ºC |
| Exact Mass | 261.17300 |
| PSA | 30.49000 |
| LogP | 3.13570 |
| Index of Refraction | 1.52 |
| HS Code | 2933399090 |
|---|
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| CL-1848C |
| Piperidine,3-dioxolan-4-yl) |
| ETOXADROL |